{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T23:07:57Z","timestamp":1788736077518,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Emerg Med"],"DOI":"10.1186\/s12873-024-01158-9","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:51:44Z","timestamp":1734529904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of droperidol use in the emergency department: a retrospective analysis of QTc prolongation and adverse events"],"prefix":"10.1186","volume":"24","author":[{"given":"Abdulmajeed M.","family":"Alshehri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin E.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Lupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy R.","family":"DeGrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylee","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"4","key":"1158_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/s0736-4679(03)00044-1","volume":"24","author":"JR Richards","year":"2003","unstructured":"Richards JR, Schneir AB. Droperidol in the emergency department: is it safe? J Emerg Med. 2003;24(4):441\u20137. https:\/\/doi.org\/10.1016\/s0736-4679(03)00044-1.","journal-title":"J Emerg Med"},{"issue":"22","key":"1158_CR2","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/ajhp\/zxaa271","volume":"77","author":"A Mattson","year":"2020","unstructured":"Mattson A, Friend K, Brown CS, Cabrera D. Reintegrating droperidol into emergency medicine practice. Am J Health Syst Pharm. 2020;77(22):1838\u201345. https:\/\/doi.org\/10.1093\/ajhp\/zxaa271.","journal-title":"Am J Health Syst Pharm"},{"issue":"9209","key":"1158_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/s0140-6736(00)02035-3","volume":"355","author":"JG Reilly","year":"2000","unstructured":"Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355(9209):1048\u201352. https:\/\/doi.org\/10.1016\/s0140-6736(00)02035-3.","journal-title":"Lancet"},{"issue":"5","key":"1158_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1213\/00000539-199411000-00028","volume":"79","author":"V Lischke","year":"1994","unstructured":"Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vettermann J. Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg. 1994;79(5):983\u20136. https:\/\/doi.org\/10.1213\/00000539-199411000-00028.","journal-title":"Anesth Analg"},{"issue":"1","key":"1158_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jemermed.2014.12.024","volume":"49","author":"J Perkins","year":"2015","unstructured":"Perkins J, Ho JD, Vilke GM, DeMers G. American Academy of Emergency Medicine Position Statement: Safety of Droperidol Use in the Emergency Department. J Emerg Med. 2015;49(1):91\u20137. https:\/\/doi.org\/10.1016\/j.jemermed.2014.12.024.","journal-title":"J Emerg Med"},{"issue":"1","key":"1158_CR6","first-page":"3","volume":"4","author":"JR Richards","year":"2003","unstructured":"Richards JR, Weiss SJ, Bretz SW, Schneir AB, Rinetti D, Derlet RW. The effects of the FDA warning on the use of droperidol by u.s. Emergency physicians. Cal J Emerg Med. 2003;4(1):3\u20139.","journal-title":"Cal J Emerg Med"},{"issue":"11","key":"1158_CR7","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2146\/ajhp060505","volume":"64","author":"CW Jackson","year":"2007","unstructured":"Jackson CW, Sheehan AH, Reddan JG. Evidence-based review of the black-box warning for droperidol. Am J Health Syst Pharm. 2007;64(11):1174\u201386. https:\/\/doi.org\/10.2146\/ajhp060505.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"1158_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2344\/anpr-67-03-14","volume":"67","author":"KJ Kramer","year":"2020","unstructured":"Kramer KJ. The Surprising Re-emergence of Droperidol. Anesth Prog. 2020;67(3):125\u20136. https:\/\/doi.org\/10.2344\/anpr-67-03-14.","journal-title":"Anesth Prog"},{"issue":"6","key":"1158_CR9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/00000542-200506000-00007","volume":"102","author":"PF White","year":"2005","unstructured":"White PF, Song D, Abrao J, Klein KW, Navarette B. Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study. Anesthesiology. 2005;102(6):1101\u20135. https:\/\/doi.org\/10.1097\/00000542-200506000-00007.","journal-title":"Anesthesiology"},{"issue":"6","key":"1158_CR10","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/00000542-200506000-00006","volume":"102","author":"B Charbit","year":"2005","unstructured":"Charbit B, Albaladejo P, Funck-Brentano C, Legrand M, Samain E, Marty J. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology. 2005;102(6):1094\u2013100. https:\/\/doi.org\/10.1097\/00000542-200506000-00006.","journal-title":"Anesthesiology"},{"issue":"4","key":"1158_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/bcp.12527","volume":"79","author":"K Tracz","year":"2015","unstructured":"Tracz K, Owczuk R. Small doses of droperidol do not present relevant torsadogenic actions: a double-blind, ondansetron-controlled study. Br J Clin Pharmacol. 2015;79(4):669\u201376. https:\/\/doi.org\/10.1111\/bcp.12527.","journal-title":"Br J Clin Pharmacol"},{"issue":"16","key":"1158_CR12","doi-asserted-by":"publisher","first-page":"e004252","DOI":"10.1161\/JAHA.117.004252","volume":"7","author":"QT Which","year":"2018","unstructured":"Which QT. Correction Formulae to Use for QT Monitoring? J Am Heart Assoc. 2018;7(16):e004252. https:\/\/doi.org\/10.1161\/JAHA.117.004252.","journal-title":"J Am Heart Assoc"},{"key":"1158_CR13","unstructured":"Corrected QT. Interval (QTc) Calculator. Mayo Clinic. Accessed June 25, 2023. https:\/\/www.mayoclinic.org\/medical-professionals\/cardiovascular-diseases\/calculators\/corrected-qt-interval-qtc-calculator\/itt-20487211"},{"issue":"1","key":"1158_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11096-016-0414-2","volume":"39","author":"E Vandael","year":"2017","unstructured":"Vandael E, Vandenberk B, Vandenberghe J, Willems R, Foulon V. Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm. 2017;39(1):16\u201325. https:\/\/doi.org\/10.1007\/s11096-016-0414-2.","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"1158_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1177\/1060028020988734","volume":"55","author":"NF Hunt","year":"2021","unstructured":"Hunt NF, McLaughlin KC, Kovacevic MP, Lupi KE, Dube KM. Safety of Intravenous Olanzapine Administration at a Tertiary Academic Medical Center. Ann Pharmacother. 2021;55(9):1127\u201333. https:\/\/doi.org\/10.1177\/1060028020988734.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"1158_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345. https:\/\/doi.org\/10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1158_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00228-017-2381-5","volume":"74","author":"CPM Heemskerk","year":"2018","unstructured":"Heemskerk CPM, Pereboom M, van Stralen K, et al. Risk factors for QTc interval prolongation. Eur J Clin Pharmacol. 2018;74(2):183\u201391. https:\/\/doi.org\/10.1007\/s00228-017-2381-5.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"1158_CR18","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.ajem.2019.09.007","volume":"38","author":"CM Gaw","year":"2020","unstructured":"Gaw CM, Cabrera D, Bellolio F, Mattson AE, Lohse CM, Jeffery MM. Effectiveness and safety of droperidol in a United States emergency department. Am J Emerg Med. 2020;38(7):1310\u20134. https:\/\/doi.org\/10.1016\/j.ajem.2019.09.007.","journal-title":"Am J Emerg Med"},{"issue":"7","key":"1158_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.gie.2006.01.052","volume":"63","author":"P Yimcharoen","year":"2006","unstructured":"Yimcharoen P, Fogel EL, Kovacs RJ, et al. Droperidol, when used for sedation during ERCP, may prolong the QT interval. Gastrointest Endosc. 2006;63(7):979\u201385. https:\/\/doi.org\/10.1016\/j.gie.2006.01.052.","journal-title":"Gastrointest Endosc"},{"key":"1158_CR20","unstructured":"Lexicomp Online. Droperidol: Lexi-Drugs. Wolters Kluwer Health. 2022. Accessed November 14, 2023. https:\/\/online.lexi.com"},{"issue":"3","key":"1158_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.annemergmed.2015.03.016","volume":"66","author":"L Calver","year":"2015","unstructured":"Calver L, Page CB, Downes MA, et al. The Safety and Effectiveness of Droperidol for Sedation of Acute Behavioral Disturbance in the Emergency Department. Ann Emerg Med. 2015;66(3):230\u2013e2381. https:\/\/doi.org\/10.1016\/j.annemergmed.2015.03.016.","journal-title":"Ann Emerg Med"},{"issue":"12","key":"1158_CR22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1177\/10600280231163192","volume":"57","author":"PJ Allen","year":"2023","unstructured":"Allen PJ, Johanson KE, Reveles KR, Neff LA, Lock AE. Comparison of Droperidol and Midazolam Versus Haloperidol and Lorazepam for Acute Agitation Management in the Emergency Department. Ann Pharmacother. 2023;57(12):1367\u201374. https:\/\/doi.org\/10.1177\/10600280231163192.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"1158_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/15563650.2018.1564324","volume":"57","author":"C Lee","year":"2019","unstructured":"Lee C, Greene SL, Wong A. The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome. Clin Toxicol (Phila). 2019;57(9):773\u20137. https:\/\/doi.org\/10.1080\/15563650.2018.1564324.","journal-title":"Clin Toxicol (Phila)"}],"container-title":["BMC Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12873-024-01158-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12873-024-01158-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12873-024-01158-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T14:04:35Z","timestamp":1734530675000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcemergmed.biomedcentral.com\/articles\/10.1186\/s12873-024-01158-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1158"],"URL":"https:\/\/doi.org\/10.1186\/s12873-024-01158-9","relation":{},"ISSN":["1471-227X"],"issn-type":[{"value":"1471-227X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Mass General Brigham (protocol # 2022P002473)). Due to the retrospective nature of the study, the ethics committee have waived the necessity of informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}